150 related articles for article (PubMed ID: 7433492)
1. Naloxone potentiates the disruptive effects of mescaline on operant responding in the rat.
Commissaris RL; Moore KE; Rech RH
Pharmacol Biochem Behav; 1980 Oct; 13(4):601-3. PubMed ID: 7433492
[TBL] [Abstract][Full Text] [Related]
2. Neurotransmitter basis of the behavioral effects of hallucinogens.
Rech RH; Commissaris RL
Neurosci Biobehav Rev; 1982; 6(4):521-7. PubMed ID: 6817241
[TBL] [Abstract][Full Text] [Related]
3. Naloxone alters the effects of LSD, DOM and quipazine on operant behavior of rats.
Mokler DJ; Commissaris RL; Henck JW; Rech RH
Pharmacol Biochem Behav; 1984 Sep; 21(3):333-7. PubMed ID: 6593750
[TBL] [Abstract][Full Text] [Related]
4. Central 5-hydroxytryptamine and the effects of hallucinogens and phenobarbital on operant responding in rats.
Commissaris RL; Lyness WH; Moore KE; Rech RH
Pharmacol Biochem Behav; 1981 May; 14(5):595-601. PubMed ID: 7243838
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of disruptive effects of dextromethorphan by naloxone on fixed-interval performance in rats.
Taşkin T
Psychopharmacology (Berl); 1986; 90(3):408-11. PubMed ID: 3097731
[TBL] [Abstract][Full Text] [Related]
6. Action of a chronic administration of mescaline in dynamic behavioural situations.
Fundaro' A; Molinengo L; Cassone MC; Orsetti M
Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(1):41-8. PubMed ID: 3704173
[TBL] [Abstract][Full Text] [Related]
7. Cyclazocine disruption of operant behavior is antagonized by naloxone and metergoline.
Henck JW; Mokler DJ; Commissaris RL; Rech RH
Pharmacol Biochem Behav; 1983 Jan; 18(1):41-5. PubMed ID: 6828536
[TBL] [Abstract][Full Text] [Related]
8. Naloxone and diprenorphine reduce responding for brain self-stimulation in a fixed-ratio schedule in rats.
Schaefer GJ; Michael RP
Pharmacol Biochem Behav; 1988 Jan; 29(1):209-12. PubMed ID: 3353428
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of the behavioral effects of 2,5-dimethoxy-4-methyl-amphetamine (DOM) by pretreatment with p-chlorophenylalanine.
Commissaris RL; Lyness WH; Moore KE; Rech RH
Pharmacol Biochem Behav; 1980 Oct; 13(4):605-8. PubMed ID: 6449015
[TBL] [Abstract][Full Text] [Related]
10. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
Schulteis G; Morse AC; Liu J
Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute morphine pretreatment on the rate-decreasing and antagonist activity of naloxone.
Young AM
Psychopharmacology (Berl); 1986; 88(2):201-8. PubMed ID: 3081932
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological and behavioral components of tolerance to LSD and mescaline in rats.
Murray TF; Craigmill AL; Fischer GJ
Pharmacol Biochem Behav; 1977 Sep; 7(3):239-44. PubMed ID: 928480
[TBL] [Abstract][Full Text] [Related]
13. The interaction of d-amphetamine and naloxone differs for rats trained on separate fixed-interval or fixed-ratio schedules of reinforcement.
Andrews JS; Holtzman SG
Pharmacol Biochem Behav; 1987 Jan; 26(1):167-71. PubMed ID: 3562487
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine increases intake of freely available and operant-contingent food in satiated rats.
Rudski JM; Thomas D; Billington CJ; Levine AS
Pharmacol Biochem Behav; 1995 Feb; 50(2):271-6. PubMed ID: 7740067
[TBL] [Abstract][Full Text] [Related]
15. Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride.
Mokler DJ; Rech RH
Pharmacol Biochem Behav; 1984 Aug; 21(2):281-7. PubMed ID: 6483939
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats.
Gellert VF; Sparber SB
J Pharmacol Exp Ther; 1977 Apr; 201(1):44-54. PubMed ID: 557543
[TBL] [Abstract][Full Text] [Related]
17. Effects of opioid antagonists and their quaternary derivatives on locomotor activity and fixed ratio responding for brain self-stimulation in rats.
Schaefer GJ; Michael RP
Pharmacol Biochem Behav; 1985 Nov; 23(5):797-802. PubMed ID: 4080766
[TBL] [Abstract][Full Text] [Related]
18. Naloxone administration impairs autoshaped learning.
Messing RB; Allen SJ; Aanonsen L; Sparber SB
Behav Neural Biol; 1989 Jan; 51(1):34-45. PubMed ID: 2705981
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of the behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) and quipazine by metergoline.
Commissaris RL; Rech RH
Pharmacol Biochem Behav; 1981 Oct; 15(4):659-62. PubMed ID: 7291270
[TBL] [Abstract][Full Text] [Related]
20. Naloxone pretreatment blocks acute morphine-induced sensitization to naltrexone.
White-Gbadebo D; Holtzman S
Psychopharmacology (Berl); 1994 Mar; 114(2):225-8. PubMed ID: 7838911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
